MeSH D010032 - otitis externa
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Alcon Research | Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone |  | 1986-11-17 |  |  |
| Neomycin, Polymyxin b | Statrol |  | 1984-11-30 |  |  | |
| ALK-Abelló | Ciprofloxacin | Otiprio | 2029-04-21 | 2015-12-10 |  |  |
| Allergan | Prednisolone, Neomycin, Polymyxin b | Poly-pred |  | 1982-01-01 |  |  |
| Trimethoprim, Polymyxin b | Polytrim |  | 1988-10-20 |  |  | |
| Ciprofloxacin | Ciprofloxacin |  | 2005-01-21 |  |  | |
| Neomycin, Polymyxin b | Neomycin Polymyxin B |  | 1986-04-08 |  |  | |
| Gramicidin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Gramicidin |  | 1987-06-11 |  |  | |
| Hydrocortisone, Neomycin, Polymyxin b | Otocort |  | 1982-01-01 |  |  | |
| Altaire Pharmaceuticals | Ciprofloxacin | Ciprofloxacin |  | 2018-05-03 |  |  |
| Altana | Hydrocortisone, Bacitracin, Neomycin, Polymyxin b | Bacitracin-neomycin-polymyxin W/ Hydrocortisone |  | 1982-01-01 |  |  |
| Amneal Pharmaceuticals | Ciprofloxacin | Ciprofloxacin |  | 2004-06-09 |  |  |
| Amring Pharmaceuticals | Ciprofloxacin | Ciprofloxacin |  | 2008-01-16 |  |  |
| Hydrocortisone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Hydrocortisone |  | 2005-10-31 |  |  | |
| ANI Pharmaceuticals | Ciprofloxacin | Ciprofloxacin |  | 2010-11-30 |  |  |
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
100%2/2
Phase 2
60%3/5
Phase 3
31%9/29
Approved: 7Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use